Novo Nordisk A/S
July 6th, 2024Weight loss stocks should grab big gains, Tema ETFs’ CEO suggests – MASHAHER
- June 25th, 2024
SEDG, POOL, CCL and more – MASHAHER
- June 25th, 2024
Novo Nordisk’s Wegovy weight loss drug approved in China – MASHAHER
- June 24th, 2024
Novo Nordisk to boost output of Wegovy, Ozempic with new NC facility – MASHAHER
- June 21st, 2024
Weight loss drug contender Zealand Pharma jumps 23% on trial results – MASHAHER
- May 26th, 2024
Digital health companies are launching programs around GLP-1s – MASHAHER
- May 25th, 2024
FDA panel votes against Novo Nordisk’s weekly insulin in type 1 diabetes patients – MASHAHER
- May 20th, 2024
Hims & Hers weight loss adds compounded GLP-1 injections – MASHAHER
- May 14th, 2024
Wegovy patients maintain weight loss for 4 years: Novo Nordisk study – MASHAHER
- May 7th, 2024
Amgen could threaten Novo Nordisk, Eli Lilly weight loss drug dominance – MASHAHER
- April 20th, 2024
Weight loss drug patients spend less on restaurants, takeout: survey – MASHAHER
- April 16th, 2024
These are the top 5 companies to work for in India, says LinkedIn – MASHAHER
No more posts
No more posts